To study the effects of the anti-TAG-72-IL-2 fusion protein in other TAG-72-positive tumor models, immunocompetent mice were injected subcutaneously with colorectal carcinoma syngeneic MC38 cells expressing cell surface TAG-72. This evidence concerns the gene IL2 and neoplasm.